Literature DB >> 18624853

A review of photodynamic therapy in cutaneous leishmaniasis.

E M van der Snoek1, D J Robinson, J J van Hellemond, H A M Neumann.   

Abstract

We present a review of six clinical studies investigating the use of photodynamic therapy (PDT) using porphyrin precursors for the treatment of Old World cutaneous leishmaniasis (CL). Thirty-nine patients with a total of 77 lesions received PDT using a range of treatment schedules following topical application of aminolevulinic acid (ALA) or methyl-aminolevulinate (MAL). The tissue response to PDT is accompanied by a mild burning sensation, erythema and reversible hypo- and hyperpigmentation. Few mechanistic studies have addressed the principles underlying the use of PDT for CL. All six reviewed papers suggest that PDT with porphyrin precursors is relatively effective in treating CL. Data are still limited, and PDT cannot at this point be recommended in routine clinical practice. The mechanism of action of this promising therapeutic modality needs to investigated further and additional controlled trials need to be performed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624853     DOI: 10.1111/j.1468-3083.2008.02805.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  Topical and Intradermal Efficacy of Photodynamic Therapy with Methylene Blue and Light-Emitting Diode in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Mônica Raquel Sbeghen; Evandra Maria Voltarelli; Tácito Graminha Campois; Elza Kimura; Sandra Mara Alessi Aristides; Luzmarina Hernandes; Wilker Caetano; Noboru Hioka; Maria Valdrinez Campana Lonardoni; Thaís Gomes Verzignassi Silveira
Journal:  J Lasers Med Sci       Date:  2015-06-28

2.  The Immunogenetic Aspects of Photodynamic Therapy.

Authors:  Chaw-Ning Lee; Tak-Wah Wong
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Photodynamic Therapy for Cancer and for Infections: What Is the Difference?

Authors:  Sulbha K Sharma; Pawel Mroz; Tianhong Dai; Ying-Ying Huang; Tyler G St Denis; Michael R Hamblin
Journal:  Isr J Chem       Date:  2012-09       Impact factor: 3.333

4.  Update in the treatment of cutaneous leishmaniasis.

Authors:  Sahar H Al-Natour
Journal:  J Family Community Med       Date:  2009-05

5.  Enhanced photodynamic leishmanicidal activity of hydrophobic zinc phthalocyanine within archaeolipids containing liposomes.

Authors:  Ana Paula Perez; Agustina Casasco; Priscila Schilrreff; Maria Victoria Defain Tesoriero; Luc Duempelmann; Juan Sebastián Pappalardo; Maria Julia Altube; Leticia Higa; Maria Jose Morilla; Patricia Petray; Eder L Romero
Journal:  Int J Nanomedicine       Date:  2014-07-10

Review 6.  Blue Light Disinfection in Hospital Infection Control: Advantages, Drawbacks, and Pitfalls.

Authors:  João Cabral; Rodrigues Ag
Journal:  Antibiotics (Basel)       Date:  2019-05-07

7.  Cutaneous leishmaniasis due to Leishmania aethiopica: A therapeutic challenge.

Authors:  Laura Mengeot; Jean-Cyr Yombi; Marie Baeck
Journal:  JAAD Case Rep       Date:  2021-12-28

8.  Evaluation of the Photodynamic Therapy with Curcumin on L. braziliensis and L. major Amastigotes.

Authors:  André Henrique Correia Pereira; Luciana Maria Cortez Marcolino; Juliana Guerra Pinto; Juliana Ferreira-Strixino
Journal:  Antibiotics (Basel)       Date:  2021-05-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.